|1.||Acland, Erinn L: 1 article (12/2015)|
|2.||Martin, Loren J: 1 article (12/2015)|
|3.||Piltonen, Marjo H: 1 article (12/2015)|
|4.||Mogil, Jeffrey S: 1 article (12/2015)|
|5.||Diatchenko, Luda: 1 article (12/2015)|
|6.||Maixner, William: 1 article (12/2015)|
|7.||Convertino, Marino: 1 article (12/2015)|
|8.||Gauthier, Josee: 1 article (12/2015)|
|9.||Dokholyan, Nikolay V: 1 article (12/2015)|
|10.||Reutelsterz, A: 1 article (03/2009)|
01/01/1991 - "Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris."
01/01/1991 - "The effects of slow-release isosorbide-5-mononitrate (IS-5-MN), 25 mg once daily, bupranolol, 50 mg once daily, and their combination on exercise-induced ST-segment depression at comparable work load, maximal work load, exercise capacity, frequency of anginal episodes and sublingual nitroglycerin consumption were studied in 30 patients with chronic stable angina pectoris. "
06/10/1979 - "[Studies of bupranolol therapy for glaucoma. "
01/01/1979 - "[Studies of bupranolol therapy for glaucoma. "
01/01/1982 - "[Longterm bupranolol therapy in glaucoma eyes: a one to two year follow up study (author's transl)]."
07/01/1981 - "[Bupranolol in the treatment of primary glaucoma]."
02/01/1981 - "[Effect of topical bupranolol on glaucoma eyes (author's transl)]."
|3.||Open-Angle Glaucoma (Glaucoma, Open Angle)
05/01/1979 - "In two previous studies the effects of topically applied 1% and 0.2% solutions of bupranolol on intraocular pressure were investigated in 21 and respectively 20 eyes with chronic uncomplicated open-angle glaucoma.--As early as 30 minutes after both solutions a very significant pressure drop, without concomittant pupillary reaction, was recorded. "
10/05/1979 - "[Improvement of the drainage of the aqueous humor in chronic glaucoma simplex after administration of bupranolol and piloeserine]."
09/10/1979 - "[The effects of oral bupranolol on intraocular pressure of primary open-angle glaucoma (author's transl)]."
05/01/1979 - "[Lowering of intraocular pressure by aqueous solution of bupranolol in chronic uncomplicated glaucoma simplex (author's transl)]."
01/01/1978 - "[The ocular hypotensive action of a 0.2% solution of betadrenol in chronic open-angle glaucoma]."
12/01/2015 - "The S enantiomer of bupranolol, a β-receptor antagonist, shows greater antinociceptive efficacy and a superior preclinical safety profile and it should be considered as a unique β-adrenergic receptor compound to advance future clinical pain studies."
12/01/2015 - "Here, we compared the antinociceptive effects of enantiomeric configurations of propranolol and bupranolol, two structurally similar nonselective β-blocking drugs, against mouse models of inflammatory and chronic pain. "
|5.||Hypertension (High Blood Pressure)
03/20/1981 - "[The treatment of hypertension with bupranolol. "
10/31/1980 - "[Treatment of high blood pressure with Betadrenol 100. "
07/13/1979 - "[Management of hypertension using Bupranolol. "
03/17/1978 - "[Effect of bupranolol on the renin-angiotensin system in essential hypertension]."
01/01/1992 - "Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol."
|2.||Ophthalmic Solutions (Eye Drops)
|3.||Adrenergic Receptors (Adrenergic Receptor)
|7.||Isosorbide Dinitrate (Isordil)